Literature DB >> 15816147

A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods.

P Horby1, C R Macintyre, P B McIntyre, G L Gilbert, M Staff, M Hanlon, L G Heron, M Cagney, C Bennett.   

Abstract

Culture for Bordetella pertussis (B. pertussis) is the traditional gold standard for laboratory diagnosis of pertussis but is insensitive, especially later in the course of illness and in vaccinated persons. Interpretation of serology is limited by the lack of an appropriate reference standard. An outbreak of pertussis in a crowded boarding-school dormitory allowed evaluation of laboratory correlates of infection. Questionnaires, serum samples and throat swabs were collected from members of the exposed group. Serum samples from unexposed controls of a similar age group were used for comparison. B. pertussis PCR was performed on throat swabs, and sera were tested for IgA antibodies against whole-cell (WC) B. pertussis antigen and IgG antibodies to pertussis toxin (PT). The Centers for Disease Control and Prevention definition for pertussis was used to define clinical cases. We evaluated the use of a previously published cut-off for PT IgG of 125 EIA units (EU)/ml. Completed questionnaires were obtained from 115 students, of whom 85 (74%) reported coughing symptoms, including 32 (28%) who met the clinical case definition for pertussis. B. pertussis was detected by PCR in 17 (15%) and WC IgA in 22 (19%) students; neither correlated with symptoms, but dormitory of residence strongly predicted PCR status. The mean PT IgG geometric mean concentration, in this situation of high pertussis exposure, correlated with severity of symptoms and was significantly higher in both symptomatic and asymptomatic children exposed during the outbreak (P < 0.001) than in control children. A cut-off for PT IgG of 125 EU/ml was too high in an outbreak situation to be sensitive enough to identify pertussis cases. A case of pertussis in a crowded boarding-school dormitory resulted rapidly in an outbreak. Serology and PCR were useful in identifying the outbreak and commencing disease control measures. The use of serology has mostly been evaluated in community serosurveys, where it is not possible to determine if immunity reflects vaccination, asymptomatic disease or symptomatic disease. This outbreak gave us the opportunity to evaluate the value of serology and PCR in the presence of confirmed exposure to pertussis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816147      PMCID: PMC2870241          DOI: 10.1017/s0950268804003401

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Bull World Health Organ       Date:  2011-07-05       Impact factor: 9.408

2.  The seroepidemiology of pertussis in Australia during an epidemic period.

Authors:  M Cagney; C R MacIntyre; P McIntyre; M Puech; A Giammanco
Journal:  Epidemiol Infect       Date:  2006-05-11       Impact factor: 2.451

3.  Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.

Authors:  Meryta L May; Suhail A Doi; David King; Jenny Evans; Jennifer M Robson
Journal:  Clin Vaccine Immunol       Date:  2011-11-30

Review 4.  Laboratory Diagnosis of Pertussis.

Authors:  Anneke van der Zee; Joop F P Schellekens; Frits R Mooi
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

5.  Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples.

Authors:  Sabine C de Greeff; Peter Teunis; Hester E de Melker; Frits R Mooi; Daan W Notermans; Bert Elvers; Joop F P Schellekens
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

6.  Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000.

Authors:  J Mossong; L Putz; Z Shkedy; F Schneider
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

7.  Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Authors:  M Riffelmann; K Thiel; J Schmetz; C H Wirsing von Koenig
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

Review 8.  What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Authors:  N Guiso; G Berbers; N K Fry; Q He; M Riffelmann; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

9.  Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity.

Authors:  Shelly Bolotin; Shelley L Deeks; Alex Marchand-Austin; Heather Rilkoff; Vica Dang; Ryan Walton; Ahmed Hashim; David Farrell; Natasha S Crowcroft
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

10.  Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practice.

Authors:  Paul L J M Mertens; Frans S Stals; Ewout W Steyerberg; Jan H Richardus
Journal:  BMC Infect Dis       Date:  2007-06-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.